Month: February 2020

Research – Orion Group Holdings (ORN) – Set Up for Positive Year Drives Higher Price Target

Posted on by Admin

Monday, March 2, 2020

Orion Group Holdings (ORN)

Set Up for Positive Year Drives Higher Price Target

Orion Group Holdings, based in Houston, Texas, is a specialty construction company within the Marine and Industrial Construction sectors, with operations focused in the continental United States and Caribbean. Revenue is split roughly 50/50 between a Marine Construction segment that provides marine facility, pipeline and structural construction services and a Commercial Concrete segment that provides turnkey concrete services in the light commercial and structural construction markets.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

A solid end to a transformational year. 4Q2019 gross profit of $19.1 million and EBITDA of $11.0 million beat our estimates of $15.2 million and $8.2 million, respectively. High backlog, improving execution and ISG restructuring create tailwinds into 2020.

YE2019 backlog moderated to $572 million, as expected, but still up 30% over YE2018 and industry fundamentals remain positive. Backlog is $341 million in Marine and $232 million in…


Get the full report on Channelchek desktop.


This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision. 

Research – Newrange Gold Corp (NRG:CA) – Additional Ground Is Staked at Pamlico Based on IP Survey Results

Posted on by Admin

Monday, February 24, 2020

Newrange Gold Corp (NRG:CA)

Additional Ground Is Staked at Pamlico Based on IP Survey Results

Newrange Gold Corp is an exploration stage company focused on acquiring and exploring exploration and evaluation assets in Colombia and the United States. The Company operates in a single reportable operating segment-the acquisition, exploration, and development of mineral properties. Some of the projects acquired by the company are Pamlico gold project in Nevada and Rocky mountain project in Colorado. The company also holds an interest in the Yarumalito property, El Dovio property and Anori property in Colombia.

Mark Reichman, Senior Research Analyst of Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

IP Survey generates new drilling targets.  Newrange Gold announced that its recently completed and interpreted Induced Polarization and Resistivity (IP) survey at the company’s Pamlico project generated several targets for its planned drilling program which is expected to commence in the first quarter of 2020.

Expanding the property to accommodate future exploration. Based on the trend and extent of anomalies revealed in the survey, Newrange acquired 105 additional claims and added 878 hectares of contiguous property bringing the Pamlico project total to 2,548 hectares. An anomaly is any variation from the norm which may indicate the presence of…



Get the full report on Channelchek desktop.

This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision. 

Research orion group holdings orn set up for positive year drives higher price target

Posted on by Admin

Monday, March 2, 2020

Orion Group Holdings (ORN)

Set Up for Positive Year Drives Higher Price Target

Orion Group Holdings, based in Houston, Texas, is a specialty construction company within the Marine and Industrial Construction sectors, with operations focused in the continental United States and Caribbean. Revenue is split roughly 50/50 between a Marine Construction segment that provides marine facility, pipeline and structural construction services and a Commercial Concrete segment that provides turnkey concrete services in the light commercial and structural construction markets.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

A solid end to a transformational year. 4Q2019 gross profit of $19.1 million and EBITDA of $11.0 million beat our estimates of $15.2 million and $8.2 million, respectively. High backlog, improving execution and ISG restructuring create tailwinds into 2020.

YE2019 backlog moderated to $572 million, as expected, but still up 30% over YE2018 and industry fundamentals remain positive. Backlog is $341 million in Marine and $232 million in…


Get the full report on Channelchek desktop.


This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision. 

Research newrange gold corp nrg ca additional ground is staked at pamlico based on ip survey results

Posted on by Admin

Monday, February 24, 2020

Newrange Gold Corp (NRG:CA)

Additional Ground Is Staked at Pamlico Based on IP Survey Results

Newrange Gold Corp is an exploration stage company focused on acquiring and exploring exploration and evaluation assets in Colombia and the United States. The Company operates in a single reportable operating segment-the acquisition, exploration, and development of mineral properties. Some of the projects acquired by the company are Pamlico gold project in Nevada and Rocky mountain project in Colorado. The company also holds an interest in the Yarumalito property, El Dovio property and Anori property in Colombia.

Mark Reichman, Senior Research Analyst of Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

IP Survey generates new drilling targets.  Newrange Gold announced that its recently completed and interpreted Induced Polarization and Resistivity (IP) survey at the company’s Pamlico project generated several targets for its planned drilling program which is expected to commence in the first quarter of 2020.

Expanding the property to accommodate future exploration. Based on the trend and extent of anomalies revealed in the survey, Newrange acquired 105 additional claims and added 878 hectares of contiguous property bringing the Pamlico project total to 2,548 hectares. An anomaly is any variation from the norm which may indicate the presence of…



Get the full report on Channelchek desktop.

This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision. 

Research – One Stop Systems Inc. (OSS) – What Does the New CEO Bring to the Table?

Posted on by Admin

Friday, February 21, 2020

One Stop Systems Inc. (OSS)

What Does the New CEO Bring to the Table?

One Stop Systems Inc is US-based company which is principally engaged in designing, manufacturing, marketing high-end systems for high performance computing (HPC) applications. The company offers custom servers, compute accelerators, solid-state storage arrays and system expansion systems. The product line of the company includes GPU Appliances, GPU Expansion, GPUs and co-processors, Flash storage arrays, Flash storage expansion, Servers, Disk Arrays, Desktop computing appliances, accessories and parts. The company delivers high-end technology to customers through the sale of equipment and software for use on their premises or through remote cloud access to secure data centres housing technology.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

David Raun Appointed Interim CEO. In a somewhat surprising move, on February 18th One Stop’s Board of Directors appointed Board member David Raun as interim president and CEO, succeeding Steve Cooper, who remains on the Board. Mr. Raun will serve while the Board undergoes a CEO search. We would not be surprised if Mr. Raun is one of the candidates.

Who Is David Raun?  Mr. Raun has served as a Board member since December 2016. Mr. Raun has over 20 years experience in the tech industry, including service as CEO of PLX Technology, Inc., which was a leading manufacturer of PCI Express switches and bridges, a key OSS product line, and where he the led the company to an acquisition by Avago (now Broadcom). We do not foresee any drastic changes in…


Get the full report on Channelchek desktop.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision. 

Research – Energy Services of America (ESOA) – Lower Revenue But Higher Margins

Posted on by Admin

Friday, February 21, 2020

Energy Services of America (ESOA)

Lower Revenue But Higher Margins

Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is primarily engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical and automotive industries, and does incidental work such as water and sewer projects. Energy Service’s other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services and other services related to pipeline construction.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Soft start to fiscal year. 1Q2020 EBITDA of $0.9 million was below our estimate due to a large project completion in 4Q2019 and limited larger projects behind it. Higher than expected gross margin of 9.1% partly offset the revenue fall off.

Adjusting FY2020 EBITDA to $7.1 million to reflect 1Q2020 operating results. Forecasted revenue of $110.1 million is lower, but EBITDA margin of 6.4% and gross margin of…



Get the full report on Channelchek desktop.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision. 

Research – TherapeuticsMD (TXMD) – Q4 2019 Earnings: Annovera is Now the Lead Asset in the Sales Bag

Posted on by Admin

Friday, February 21, 2020

TherapeuticsMD Inc. (TXMD)

Q4 2019 Earnings: Annovera is Now the Lead Asset in the Sales Bag

(current) TherapeuticsMD, Inc. is a women’s healthcare company focused on developing and commercializing products targeted exclusively for women. It manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics, under our vitaMedMD’ and BocaGreenMD’ brands. The company is currently developing advanced hormone therapy pharmaceutical products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. It is also evaluating various other potential indications for our hormone technology, including oral contraception, preterm birth, vulvar and vaginal atrophy, and premature ovarian failure.

Ahu Demir, Ph.D., Biotechnology Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Annovera sales exceeded expectations and became the lead commercial focus for the company. Annovera reached $5.8 mm in the fourth quarter compared to $0.4 mm in the previous quarter. Total revenue numbers in F2019 exceeded our and street’s expectations, mainly attributed to strong Annovera sales. Thus far, the product was soft launched, the full launch is anticipated on March 1st, 2020.

Increasing our F2020 estimates primarily based on Annovera sales. We now forecast $111 mm in revenue compared to $82 mm in 2020, solely based on Annovera sales ($42 mm versus $14 mm previously). We are maintaining our F2021 forecast of $207 mm by lowering Imvexxy/Bijuva and…



Get the full report on Channelchek desktop.

This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision. 

Research therapeuticsmd txmd q4 2019 earnings annovera is now the lead asset in the sales bag

Posted on by Admin

Friday, February 21, 2020

TherapeuticsMD Inc. (TXMD)

Q4 2019 Earnings: Annovera is Now the Lead Asset in the Sales Bag

(current) TherapeuticsMD, Inc. is a women’s healthcare company focused on developing and commercializing products targeted exclusively for women. It manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics, under our vitaMedMD’ and BocaGreenMD’ brands. The company is currently developing advanced hormone therapy pharmaceutical products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. It is also evaluating various other potential indications for our hormone technology, including oral contraception, preterm birth, vulvar and vaginal atrophy, and premature ovarian failure.

Ahu Demir, Ph.D., Biotechnology Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Annovera sales exceeded expectations and became the lead commercial focus for the company. Annovera reached $5.8 mm in the fourth quarter compared to $0.4 mm in the previous quarter. Total revenue numbers in F2019 exceeded our and street’s expectations, mainly attributed to strong Annovera sales. Thus far, the product was soft launched, the full launch is anticipated on March 1st, 2020.

Increasing our F2020 estimates primarily based on Annovera sales. We now forecast $111 mm in revenue compared to $82 mm in 2020, solely based on Annovera sales ($42 mm versus $14 mm previously). We are maintaining our F2021 forecast of $207 mm by lowering Imvexxy/Bijuva and…



Get the full report on Channelchek desktop.

This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision. 

Research one stop systems inc- oss what does the new ceo bring to the table

Posted on by Admin

Friday, February 21, 2020

One Stop Systems Inc. (OSS)

What Does the New CEO Bring to the Table?

One Stop Systems Inc is US-based company which is principally engaged in designing, manufacturing, marketing high-end systems for high performance computing (HPC) applications. The company offers custom servers, compute accelerators, solid-state storage arrays and system expansion systems. The product line of the company includes GPU Appliances, GPU Expansion, GPUs and co-processors, Flash storage arrays, Flash storage expansion, Servers, Disk Arrays, Desktop computing appliances, accessories and parts. The company delivers high-end technology to customers through the sale of equipment and software for use on their premises or through remote cloud access to secure data centres housing technology.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

David Raun Appointed Interim CEO. In a somewhat surprising move, on February 18th One Stop’s Board of Directors appointed Board member David Raun as interim president and CEO, succeeding Steve Cooper, who remains on the Board. Mr. Raun will serve while the Board undergoes a CEO search. We would not be surprised if Mr. Raun is one of the candidates.

Who Is David Raun?  Mr. Raun has served as a Board member since December 2016. Mr. Raun has over 20 years experience in the tech industry, including service as CEO of PLX Technology, Inc., which was a leading manufacturer of PCI Express switches and bridges, a key OSS product line, and where he the led the company to an acquisition by Avago (now Broadcom). We do not foresee any drastic changes in…


Get the full report on Channelchek desktop.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision. 

Research energy services of america esoa lower revenue but higher margins

Posted on by Admin

Friday, February 21, 2020

Energy Services of America (ESOA)

Lower Revenue But Higher Margins

Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is primarily engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical and automotive industries, and does incidental work such as water and sewer projects. Energy Service’s other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services and other services related to pipeline construction.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Soft start to fiscal year. 1Q2020 EBITDA of $0.9 million was below our estimate due to a large project completion in 4Q2019 and limited larger projects behind it. Higher than expected gross margin of 9.1% partly offset the revenue fall off.

Adjusting FY2020 EBITDA to $7.1 million to reflect 1Q2020 operating results. Forecasted revenue of $110.1 million is lower, but EBITDA margin of 6.4% and gross margin of…



Get the full report on Channelchek desktop.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision. 

Diabetes Panel From NobleCon16 – Type 1 Diabetes: A Functional Cure Could Be Imminent

Posted on by Admin

Type 1 Diabetes: A Functional Cure Could Be Imminent
Tuesday, February 18 – 10:00am – 11:00am – Terrace Ballroom B

A medical cure, not an improved treatment, for T1D, will be the discussion by leading medical researchers in the field. Accelerated advancements that began by an unplanned meeting by two of our panelists during NobleCon14 hatched an idea that is now leading to promising clinical study results. The panel will also include a famous advocate and T1D sufferer, who is elevating the voice of those with diabetes with his national podcast. The novel approach toward a cure and clinical study results will be central to the presentation.

  • Dr. Camillo Ricordi, Director of the Diabetes Research Institute at the University of Miami School of Medicine
  • Dr. Matthias von Herrah, MD, Founder of the Type 1 Diabetes Center at La Jolla Institute for Immunology
  • Dr. Bastiano Sanna, President, and COO of Semma Therapeutics
  • Dr. Steven Perrin, CEO, and co-Founder of Anelixis Therapeutics.
  • Eric Paslay, Platinum-selling songwriter/performer, Owner of Apple Podcast Level With Me
  • Nathan Cali, Managing Director, Head of Healthcare Investment and Merchant Banking at Noble Capital Markets

Mining Panel From NobleCon16 – Creating Shareholder Value in the Mining Sector: What is the Recipe?

Posted on by Admin

Creating Shareholder Value in the Mining Sector: What is the Recipe?

Differentiation between mining companies and understanding what efforts have paid off better than others is a big part of understanding shareholder value. There will be a look at the Fraser ranking of mining jurisdictions and recent movement of companies within the rankings and where they operate. Discussions will also center on who is moving up, moving down, and thoughts from the panel regarding the survey and the jurisdictions where they operate. The panelists will answer the questions: Should investors focus more on financial returns or production growth?

  • Trey Wasser, President, CEO, and Director, Ely Gold Royalties Inc.
  • Scott Hicks, Lumina Gold Corp., VP, Corporate Development and Communications
  • Robert Archer, CEO, and Director, Newrange Gold Corp.
  • Igor Gonzales, CEO, and President, Sierra Metals
  • Greg Crowe, CEO, and President, Silver One Resources
  • Dale Mah, VP Corporate Development Endeavour Silver
  • Mark Reichman, (Moderator) Senior Research Analyst, Noble Capital Markets

Inflammasomes Panel From NobleCon16 – Inflammasome Inhibitors: The Next Generation of Innovative Immunotherapy Agents

Posted on by Admin

Inflammasome Inhibitors: The Next Generation of Innovative Immunotherapy Agents

Recent breakthroughs in regulating inflammasomes will be discussed by experts on the leading edge of new discovery and therapies. Inflammatory disorders, including Alzheimer’s, inflammatory bowel disease, multiple sclerosis, Crohn’s, non-alcoholic fatty liver disease, chronic kidney disease, lupus, diabetes, and cancer, affect 5-7% of Western populations. The companies represented on this panel could potentially translate current research into future treatments.

  • Paul Ashton, PhD., Co-Founder & CEO of Inflammasome Therapeutics, Inc.
  • Gary Glick, PhD., Co-Founder & Executive Chairman of IFM Therapeutics and Michigan Professor of Chemistry
  • Steve Glover, Co-Founder, President & CEO of Zyversa Therapeutics, Inc.
  • Robert W. Keane, PhD., Professor Physiology & Biophysics, Neurological Surgery & Microbiology, and Immunology at the University of Miami, and co-founder of InflamaCore, LLC

  • Clay B. Thorp, General Partner at Hatteras Venture Partners